We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current MED market cap is 191.41M. The company's latest EPS is USD 9.0891 and P/E is 1.91.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 235.87M | 191.02M | 174.74M | 168.56M | 140.16M |
| Operating Income | 25.51M | 8.68M | 7.94M | -5.38M | 2.11M |
| Net Income | 23.13M | 6.04M | 8.32M | -8.15M | 1.13M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 713.67M | 934.84M | 1.53B | 1.6B | 1.07B |
| Operating Income | 91.04M | 134.16M | 216.24M | 184.81M | 126.4M |
| Net Income | 77.92M | 102.86M | 164.03M | 143.57M | 99.42M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 320.02M | 309.91M | 302.76M | 293.53M | 291.24M |
| Total Liabilities | 126.98M | 108.43M | 91.8M | 88.25M | 83.9M |
| Total Equity | 193.04M | 201.48M | 210.96M | 205.28M | 207.34M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 194.65M | 276.08M | 398.33M | 316.21M | 309.91M |
| Total Liabilities | 89.82M | 118.84M | 195.85M | 161.17M | 108.43M |
| Total Equity | 104.83M | 157.25M | 202.47M | 155.04M | 201.48M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 137.14M | 147.66M | 7.28M | 20.35M | 29.42M |
| Investing | -50.32M | -61.05M | -2.78M | -5.31M | -7.09M |
| Financing | -61.88M | -79.79M | -1.49M | -1.51M | -1.51M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 84.26M | 145.2M | 94.55M | 194.57M | 147.66M |
| Investing | -6.33M | -1.28M | -29.06M | -11.41M | -61.05M |
| Financing | -82.32M | -57.14M | -125.13M | -199.58M | -79.79M |
| Market Cap | 191.41M |
| Price to Earnings Ratio | 1.91 |
| Price to Sales Ratio | 0.18 |
| Price to Cash Ratio | 2.01 |
| Price to Book Ratio | 0.94 |
| Dividend Yield | - |
| Shares Outstanding | 10.94M |
| Average Volume (1 week) | 193.54k |
| Average Volume (1 Month) | 194.85k |
| 52 Week Change | -73.63% |
| 52 Week High | 76.42 |
| 52 Week Low | 17.0692 |
| Spread (Intraday) | 0.41 (2.35%) |
| Company Name | Medifast Inc |
| Address |
3411 silverside road tatnall wilmington, delaware 19810 |
| Website | https://www.medifastinc.com |
| Industry | food preparations, nec (2099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
